Browse Drug Recalls
6,228 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6,228 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6,228 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Dec 17, 2018 | Sermorelin 9 mg injection, Rx Only, Promise Pharmacy Compounding Specialists ... | Lack of sterility assurance. | Class II | Promise Pharmacy, LLC |
| Dec 17, 2018 | Ipamorelin+Modified GRF 1-29, 9 mg/5mg injection, Rx Only, Promise Pharmacy C... | Lack of sterility assurance. | Class II | Promise Pharmacy, LLC |
| Dec 17, 2018 | Multi Trace, Zinc/Copper/Manganese/Selenium 5mg/1mg/0.5mg/60mcg/ml, injection... | Lack of sterility assurance. | Class II | Promise Pharmacy, LLC |
| Dec 14, 2018 | Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%),... | Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain unde... | Class I | Results RNA, LLC |
| Nov 19, 2018 | Human Chorionic Gonadotropin 3000 IU, Rx only, Pharm D. Solutions 1304 South ... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Pharm D Solutions, LLC |
| Nov 5, 2018 | puriton EYE RELIEF DROPS, 0.5 oz (15 ml) bottle, Kadesh Inc., NDC#7079600115,... | Non-Sterility: Product manufactured under non-sterile production conditions. | Class I | Kadesh International |
| Oct 31, 2018 | BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in n... | Lack of Assurance of Sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 29, 2018 | Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in... | Defective Container: vial defect was identified that could potentially impact the container closu... | Class II | GE Healthcare Inc. Life Sciences |
| Oct 19, 2018 | Phenylephrine 25 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/... | Lack of assurance of sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 19, 2018 | Phenylephrine 30 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/... | Lack of assurance of sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 19, 2018 | Hydromorphone (0.2 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/... | Lack of assurance of sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 19, 2018 | Fentanyl (10 mcg/mL) in NS 1 mL (in 3mL BD Syringe), Rx only, Advanced Pharma... | Lack of assurance of sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 19, 2018 | Morphine (1 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Ave... | Lack of assurance of sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 17, 2018 | Testosterone 25 mg pellet, 1 count (NDC: 69761-125-01) and 30 count vials (ND... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 15mg pellet, 1 count (NDC 69761-015-01), 6 count (NDC 69761-015-06)... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 50mg pellet, 1 count (NDC 69761-150-01), 6 count (NDC 69761-150-... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 6 mg pellet, 1 count (NDC 69761-006-01), 6 count (NDC 69761-006-06)... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 12.5mg pellet, 1 count (NDC 69761-112-01), 6 count (NDC 69761-11... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 18mg pellet, 1 count (NDC 69761-018-01), 6 count (NDC 69761-018-06)... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 12.5mg pellet, 1 count (NDC 69761-012-01), 6 count (NDC 69761-012-0... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 100mg pellet, 1 count (NDC 69761-110-01), 6 count (NDC 69761-110... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 10mg pellet, 1 count (NDC 69761-010-01), 6 count (NDC 69761-010-06)... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Estradiol 25mg pellet, 1 count (NDC 69761-025-01), 6 count (NDC 69761-025-06)... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 200mg pellet, 1 count (NDC 69761-120-01), 6 count (NDC 69761-120... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 87.5mg pellet, 1 count (NDC 69761-187-01), 6 count (NDC 69761-18... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 37.5 mg pellet, 1 count (NDC 69761-137-01), 6 count (NDC 69761-1... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 17, 2018 | Testosterone 200 mg/Anastrozole 20 mg pellet, 1 count (NDC 69761-222-01), 6 c... | Lack of Assurance of Sterility | Class II | Qualgen, LLC |
| Oct 15, 2018 | Cidofovir injection 375 mg/mL (75 mg/mL) vial Injection, 5 mL vials, Rx Only,... | Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle | Class II | Heritage Pharmaceuticals, Inc. |
| Oct 8, 2018 | 0.9% Sodium Chloride Injection, USP Rx Only a) 250 mL NDC 0409-7983-02; b) 15... | Lack of Assurance of Sterility; bags have the potential to leak | Class II | ICU Medical Inc |
| Oct 8, 2018 | 5% Dextrose Injection, USP, Rx Only, a) 25 mL NDC 0409-7923-20; b) 250 mL NDC... | Lack of Assurance of Sterility; bags have the potential to leak | Class II | ICU Medical Inc |
| Sep 20, 2018 | Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Steril... | Lack of assurance of sterility: loss of container integrity. | Class II | Pfizer Inc. |
| Sep 19, 2018 | Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, ... | Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. Th... | Class II | Pfizer Inc. |
| Sep 10, 2018 | Bi-Mix Injection (Alprostadil 80 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, Ho... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | QM-4A Quadmix 5 mL 30 PA-2PH-150A-Atropine 0.4 mg Aqueous Solution, Pharm D S... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Glycerin 72% (Lidocaine/Epi 2:1) Injectable, Pharm D Solutions, Houston, Texa... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/20 mcg Powder Pharm D S... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Vigamox Oph. Solution Pharm D Solutions, Houston, Texas --- NDC 69699-0304-05 | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Acetylcysteine Injection 10 mg/5 mL (2 mg/mL), Pharm D Solutions, Houston, Te... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Bi-Mix Injection, (Alprostadil 40 mcg/Lidocaine 2 mg/mL) Pharm D Solutions, H... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Reck Injection, Pharm D Solutions, Houston, Texas --- NDC 69699-1459-50 | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Beta-complex B-1, B-6, B-3, B-12, B-5 100, 2.54 Injectable, Pharm D Solutions... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Caffeine and Sodium Benzoate Injection 125 mg/125 mg/mL Injectable Pharm D So... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Ascorbic Acid 500 mg/mL Solution Pharm D Solutions, Houston, Texas --- NDC 69... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | HCG Lyophilized 5000 IU Injectable Pharm D Solutions, Houston, Texas ---- NDC... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Arginine Injections 100 mcg/mL, Pharm D Solutions, Houston, Texas NDC 69699-1... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Slenderella Compound Injectable, Pharm D Solutions, Houston, Texas --- NDC 69... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | HCG 3000 Unit Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1738-10 | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
| Sep 10, 2018 | Sermorelin/GHRP-2 6 mg/6 mg Powder, Pharm D Solutions, Houston, Texas --- NDC... | Lack of Assurance of Sterility | Class II | Pharm D Solutions, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.